A five-year retrospective study shows increasing rates of antimicrobial drug resistance in Cabo Verde for both Staphylococcus aureus and Escherichia coli

•First antimicrobial resistance survey in clinical isolates in Cabo Verde•Increase in methicillin and extendedspectrum beta-lactamase resistance•Generation of baseline data for implementation of the national action plan•Overall susceptibility profile in Cabo Verde comparable to countries of the regi...

Full description

Saved in:
Bibliographic Details
Published inJournal of global antimicrobial resistance. Vol. 22; pp. 483 - 487
Main Authors Monteiro, Tamar, Wysocka, Magdalena, Tellez, Elena, Monteiro, Ofelia, Spencer, Luzia, Veiga, Elisa, Monteiro, Sandra, de Pina, Carine, Gonçalves, Deisy, de Pina, Sandrine, Ludgero-Correia, Antonio, Moreno, Joao, Conceição, Teresa, Aires-de-Sousa, Marta, de Lencastre, Herminia, Gray, Laura J, Pareek, Manish, Jenkins, David R., Beleza, Sandra, Oggioni, Marco R., Araujo, Isabel Inês
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.09.2020
Elsevier
Online AccessGet full text

Cover

Loading…
More Information
Summary:•First antimicrobial resistance survey in clinical isolates in Cabo Verde•Increase in methicillin and extendedspectrum beta-lactamase resistance•Generation of baseline data for implementation of the national action plan•Overall susceptibility profile in Cabo Verde comparable to countries of the region Objectives: Data on baseline drug resistance important in informing future antimicrobial stewardship programs. So far, no data on the antimicrobial drug resistance of clinical isolates available for the African archipelago of Cabo Verde. Methods: We performed a retrospective analysis over years (2013-17) of the drug susceptibility profiles of clinical isolates in the two main hospitals of Cabo Verde. For Escherichia coli and Staphylococcus aureus, representing 47% and 26% of all clinical isolates, the antimicrobial drug resistance profile was reported for six representative drugs. Results: For E. coli we detected an increase in resistance to ampicillin, amoxicillin/clavulanic acid, ceftriaxone, ciprofloxacin and trimethoprim-and for S. aureus to methicillin, erythromycin and trimethoprim-sulfamethoxazole. This increase in both the most commonly isolated bacterial pathogens is alarm as it might compromise empirical treatment in a setting with limited access to laboratory testing. Conclusions: When compared to the published low resistance rates in carriage isolates, the more alarming situation in clinical isolates for S. aureus might encourage antimicrobial stewardship programs to reduce in hospital settings, possibly as part of the Cabo Verdean national plan against antimicrobial drug resistance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2213-7165
2213-7173
DOI:10.1016/j.jgar.2020.04.002